Bupropion Tablets and Sustained-Release Tablets and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Bupropion Tablets and Sustained-Release Tablets and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Tablets and Sustained-Release Tablets-Insulin glulisine
- Bupropion Tablets and Sustained-Release Tablets-Insulin Glulisine (Cartridges and Pens)
- Bupropion Tablets and Sustained-Release Tablets-Insulin Glulisine (Vials)
- Bupropion Tablets and Sustained-Release Tablets-Insulin glulisine Subcutaneous
- Bupropion Tablets and Sustained-Release Tablets-Insulin human inhaled Inhalation
- Bupropion Tablets and Sustained-Release Tablets-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Burapren Injection
- Insulin glargine, recombinant Subcutaneous-Burn-O-Jel Topical application
- Insulin glargine, recombinant Subcutaneous-Burnamycin Topical application
- Insulin glargine, recombinant Subcutaneous-Burosumab
- Insulin glargine, recombinant Subcutaneous-Burosumab-twza
- Insulin glargine, recombinant Subcutaneous-Burosumab-twza Subcutaneous